Tech Company Financing Transactions
Cardioxyl Pharmaceuticals Funding Round
On 8/2/2010, Cardioxyl Pharmaceuticals landed $15 million in investment from Aurora Funds and New Enterprise Associates.
Transaction Overview
Aurora Funds (Jeffrey Clark)
New Enterprise Associates (James Barrett)
Company Information
Chapel Hill, NC 27517
USA
Management Team
Browse more venture capital transactions:
Prev: 8/2/2010: Avedro venture capital transaction
Next: 8/2/2010: mFoundry venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs